Insights on the Global Heparin Market 2020-2024: COVID-19 Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2024 - Technavio

NEW YORK, March 3, 2021 /PRNewswire/ --The heparin market is expected to grow by USD 941.2 mn, progressing at a CAGR of almost 3% during the forecast period. Get Free Sample Report in MINUTES

The increasing prevalence of chronic conditions is one of the major factors propelling market growth.

More details: https://www.technavio.com/report/heparin-market-industry-analysis

Heparin Market: Route of administration Landscape

Based on the product, the subcutaneous injection segment is expected to witness lucrative growth during the forecast period.

Heparin Market: Geographic Landscape

By geography, Europe is going to have a lucrative growth during the forecast period. About 23% of the market's overall growth is expected to originate from Europe. Germany and the UK are the key markets for heparin in Europe.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Related Reports on Health Care Include:

• Antifungal Drugs Market by Route of Administration and Geography - Forecast and Analysis 2020-2024 - The antifungal drugs market size has the potential to grow by USD 2.50 billion during 2020-2024, and the market's growth momentum will accelerate during the forecast period. To get extensive research insights: Get a FREE sample report in minutes
   
• Radiation Oncology Market by Product and Geography - Forecast and Analysis 2020-2024- The radiation oncology market size has the potential to grow by USD 1.70 billion during 2020-2024, and the market's growth momentum will accelerate during the forecast period. To get extensive research insights: Get a FREE sample report in minutes

Companies Covered:

• Aspen Pharmacare Holdings Ltd.
• Baxter International Inc.
• Eisai Co. Ltd.
• Fresenius SE & Co. KGaA
• Hikma Pharmaceuticals Plc
• Laboratorios Farmaceuticos Rovi SA
• Mylan NV
• Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd.
• Pfizer Inc.
• Sanofi.

What our reports offer:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers market data for 2020, 2021, until 2025
• Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio's in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Parent market
• Market characteristics
• Market segmentation analysis
• Value chain analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

• Market segmentation by product
• Comparison by product
• Low-molecular-weight heparin - Market size and forecast 2019-2024
• Others - Market size and forecast 2019-2024
• Market opportunity by product

PART 07: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION

• Market segmentation by route of administration
• Comparison by route of administration
• Subcutaneous injection - Market size and forecast 2019-2024
• Intravenous/infusion - Market size and forecast 2019-2024
• Market opportunity by route of administration

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• Europe - Market size and forecast 2019-2024
• North America - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 12: MARKET TRENDS

• Increasing R&D activities and new therapeutic applications of heparin
• Advent of biosimilar low-molecular-weight heparin
• Development of drugs to remove heparin after surgery

PART 13: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 14: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Aspen Pharmacare Holdings Ltd.
• Baxter International Inc.
• Eisai Co. Ltd.
• Fresenius SE & Co. KGaA
• Hikma Pharmaceuticals Plc
• Laboratorios Farmaceuticos Rovi SA
• Mylan NV
• Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd.
• Pfizer Inc.
• Sanofi

PART 15: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 16: EXPLORE TECHNAVIO

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
Report Page:https://www.technavio.com/report/heparin-market-industry-analysis

SOURCE Technavio